Clinical Trials
- Diabetes
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
- Ages10 years - 17 years
- GenderBoth
- Diabetes
Type 2 Diabetes Ultrasound Study
- Ages21 years - 75 years
- GenderBoth
- Diabetes
Affordable Housing and Diabetes
- Ages18 years and older
- GenderBoth
- Diabetes
Reversibility of brain glucose transport and metabolism in T2DM
- Ages18 years - 60 years
- GenderBoth
- Diabetes
Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes
- Diabetes
Metabolic Changes Induced by a Very Low Carbohydrate Diet in Youth With Type 1 Diabetes
- Ages12 years - 24 years
- GenderBoth